NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
S Friberg, AM Nyström - Journal of Nanobiotechnology, 2016 - Springer
This review is written with the purpose to review the current nanomedicine literature and
provide an outlook on the developments in utilizing nanoscale drug constructs in treatment …
provide an outlook on the developments in utilizing nanoscale drug constructs in treatment …
Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin
New polymeric biomaterials and nanomedicines targeting cancer cells are highly required
because of their potential clinical applications. Gene therapy enjoys high popularity as …
because of their potential clinical applications. Gene therapy enjoys high popularity as …
Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury
W Gao, J Li - Journal of nanobiotechnology, 2017 - Springer
Background Traumatic spinal cord injury (SCI) includes the primary insult as well as a
sequela of biochemical and cellular cascades that amplifies the initial injury. This …
sequela of biochemical and cellular cascades that amplifies the initial injury. This …
Current non-viral siRNA delivery systems as a promising treatment of skin diseases
Background: Gene therapy is a new approach to discover and treat many diseases. It has
attracted considerable attention from researchers in the last decades. The gene therapy …
attracted considerable attention from researchers in the last decades. The gene therapy …
Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications
AE Sirica, JA Almenara, C Li - Experimental and molecular pathology, 2014 - Elsevier
Periostin is a modular glycoprotein frequently observed to be a major constituent of the
extracellular milieu of mass-forming intrahepatic cholangiocarcinoma and other …
extracellular milieu of mass-forming intrahepatic cholangiocarcinoma and other …
Calcium–siRNA nanocomplexes: What reversibility is all about
E Ruvinov, O Kryukov, E Forti, E Korin… - Journal of controlled …, 2015 - Elsevier
Gene silencing using small interfering RNA (siRNA) relies on the critical need for a safe and
effective carrier, capable of strong but reversible complexation, siRNA protection, cellular …
effective carrier, capable of strong but reversible complexation, siRNA protection, cellular …
Delivery of RNAi-based therapeutics for bone regeneration
Abstract Purpose of Review The clinical significance, target pathways, recent successes,
and challenges that preclude translation of RNAi bone regenerative approaches are …
and challenges that preclude translation of RNAi bone regenerative approaches are …
HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer
A MG, A KS, U BS, R PL, S HP… - ACS Applied Materials …, 2024 - ACS Publications
The present study investigated the concurrent delivery of antineoplastic drug, doxorubicin,
and HER2 siRNA through a targeted theranostic metallic gold nanoparticle designed using …
and HER2 siRNA through a targeted theranostic metallic gold nanoparticle designed using …
[HTML][HTML] Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies
M Mehrabani, S Mohammadyar… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Pulmonary fibrosis (PF) is the end stage of severe lung diseases, in which the lung
parenchyma is replaced by fibrous scar tissue. The result is a remarkable reduction in …
parenchyma is replaced by fibrous scar tissue. The result is a remarkable reduction in …
Cetuximab–siRNA conjugate linked through cationized gelatin knocks down KRAS G12C mutation in NSCLC sensitizing the cells toward gefitinib
K Sreedurgalakshmi, R Srikar… - … in Cancer Research …, 2021 - journals.sagepub.com
Delivery of small-interfering RNA (siRNA) has been of great interest in the past decade for
effective gene silencing. To overcome synthetic and regulatory challenges posed by …
effective gene silencing. To overcome synthetic and regulatory challenges posed by …